申请人:EGIS GYOGYSZERGYAR RT.
公开号:EP0694299A1
公开(公告)日:1996-01-31
The subject matter of the invention is the use of [a] bicycloheptane derivative(s) of formula
wherein
Rrepresents a phenyl or a benzyl group,
R₁ and R₂ ,which may be the same or different stand for straight or branched chained alkyl groups or one of R₁ and R₂ is hydrogen and the other is a straight or branched chained alkyl group,
Adenotes a straight or branched chained alkylene group and
∼represents a valence bond,
and [an] N-oxide(s) as well as [an] optical isomer(s) thereof and mixtures of the optical isomers and [an] acid addition salt(s) and quaternary ammonium derivative(s) of the bicycloheptane derivatives of formula I as well as [an] optical isomer(s) thereof and mixtures of the optical isomers for preparing medicaments for the treatment of diseases and disorders which are connected with the influence on the peripheral cholecystokinin (CCK) system.
本发明的主题是使用式[a]双环庚烷衍生物
式中
R 代表苯基或苄基、
R₁ 和 R₂,可以相同或不同,代表直链或支链烷基,或 R₁ 和 R₂ 中的一个是氢,另一个是直链或支链烷基、
表示直链或支链亚烷基,以及
∼代表价键、
式 I 的双环庚烷衍生物的[一种]N-氧化物及其[一种]光学异构体和光学异构体的混合物以及[一种]酸加成盐和季铵衍生物及其[一种]光学异构体和光学异构体的混合物,用于制备治疗与影响外周胆囊收缩素(CCK)系统有关的疾病和失调的药物。